The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance

Exclusion Criteria

• •Adults unable to consent
• •Individuals less than 18 years of age
• •Prisoners
• •Pregnant women.
• •Known contradictions or sensitivities to study medication (oxymetazoline)
• •Ocular surgery within the past 3 months or refractive surgery within the past six months
• •Grossly abnormal lid margins, anatomical abnormalities, previous eyelid or orbital surgery
• •Variable ptosis or eyelid position (e.g., myasthenia gravis, thyroid eye disease, or blepharospasm)
• •Any ocular or systemic condition that, in the opinion of the investigator, would confound study data, interfere with the subject's study participation, or affected the subject's safety or trial parameters
• •Presence of an active ocular infection
• •Prior (within 5 days of beginning study treatment) use of eye whiteners (eg, vasoconstrictors), decongestants, antihistamines (including over the counter and herbal topical ophthalmic medications), phenylephrine dilating drops, any other topical ophthalmic agents
• •Inability to sit comfortably for 15 - 30 minutes